Item 2. Unregistered Sales of Equity Securities
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In May 2024, our Board of Directors authorized a share repurchase program under which LP was authorized to repurchase up to $250 million (the 2024 Share Repurchase Program) of its outstanding common stock. During the quarter ended March 31, 2025, we repurchased 563,158 shares of our common stock at an average price of $108.55 per share through market purchases pursuant to the 2024 Share Repurchase Program. At March 31, 2025, we had an aggregate of $177 million of repurchase authorization remaining under the 2024 Share Repurchase Program. LP may initiate, discontinue, or resume purchases of its common stock under the 2024 Share Repurchase Program in the open market, in block, and in privately negotiated transactions, including under Rule 10b5-1 plans, at times and in such amounts as management deems appropriate without prior notice, subject to market and business conditions, regulatory requirements, and other factors.
The following amount of our common stock was repurchased under this authorization during the quarter ended March 31, 2025:
Period Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Purchase Plans or Programs 1
Approximate Dollar Value of Shares Available for Repurchase Under the Plans of Programs
(in millions)
January 1 - January 31, 2025 305,923 $ 111.43 305,923 $ 204
February 1 - February 28, 2025 147,401 $ 115.60 147,401 $ 187
March 1 - March 31, 2025 109,834 $ 91.05 109,834 $ 177
Total for First Quarter 2025 563,158 $ 108.55 563,158
1 On May 7, 2024, LP’s Board of Directors authorized the 2024 Share Repurchase Program under which LP may repurchase shares of its common stock totaling up to $250 million. As of March 31, 2025, LP had an aggregate of $177 million of repurchase authorization remaining under the 2024 Share Repurchase Program.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.